RxDoctor Payments DataLook up a doctor →

Cole Wootton, MD

Urology · Elk City, OKNPI 1881828556

Payments from drug & device makers

$9,514in general payments, 2019–2025

Across 421 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Astellas Pharma US Inc$1K
  • AbbVie$981
  • Boston Scientific$886
  • Pfizer$638
  • Neotract Inc.$627
  • plus $4K from 39 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)63$1,526
Astellas Pharma US Inc73$1,079
AbbVie(2 entities)65$981
Boston Scientific31$886
Pfizer30$638
Neotract Inc.6$627
Johnson & Johnson25$537
Axonics, Inc.10$394
Sumitomo Pharma America, Inc.16$356
Myriad Genetic Laboratories, Inc.23$299
Healthtronics Stone Solutions, LLC1$205
Profound Medical Corp.2$201
Teleflex LLC2$197
Urogen Pharma, Inc.3$116
Verity Pharmaceuticals Inc.6$111
Blue Earth Diagnostics6$109
Myovant Sciences Inc.6$108
Abbott2$99
Accord Healthcare, Inc.6$99
Agiliti Surgical, Inc.1$90
Tolmar Pharmaceuticals, Inc.6$87
Endo Pharmaceuticals Inc.5$78
Progenics Pharmaceuticals, Inc.3$59
Caldera Medical, Inc2$52
Ferring Pharmaceuticals Inc.3$50
Calyxo, Inc.1$48
Travere Therapeutics, Inc.2$43
Merck2$42
Ambu Inc.2$38
Tolmar, Inc.2$37
Antares Pharma, Inc.2$36
AstraZeneca1$35
Novartis1$28
Dendreon Pharmaceuticals LLC1$25
Innovation Technologies Inc1$24
Civco Medical Instruments1$20
Millicent US Inc1$20
Immunitybio, Inc.1$20
Sun Pharmaceutical Industries Inc.1$19
Trevena, Inc.1$19
Urovant Sciences Inc1$19
Hollister Incorporated1$16
Coloplast1$15
180 Medical, Inc.1$14
Clarus Therapeutics Inc.1$12

How this compares

$9,514 in reported general payments places this provider in the 75th percentile of 145 urology providers in Oklahoma.

See all urology providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$462,969
Medicare patients
693
Services billed
8,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Elk City

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →